Login

Sander Geophysics receives the 202 Employer Award.|Luise Sander is co-presidents of Sander Geophysics 00:10:00

Share On Facebook Share On Twitter

Luise Sander is co-presidents of Sander Geophysics

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Philippe Brassac Discusses Crédit Agricole's Financial Performance and Responsible Investment Challenges | Philippe Brassac , CEO ,  Crédit Agricole SA .
00:10:00
Tara Swart advises against making any financial or investment decisions based solely on predictions of profitability, as discussed in The Diary Of A CEO.|Ken Fisher, founder of Fisher Investments
00:10:00
Clarivate assists clients in finding, safeguarding, and promoting their inventions | JONATHAN GEAR, CEO, Clarivate PLC
00:10:00
Supercharges you to go from zero to one quickly|Erik Torenberg,Co-Founder & Partner,Village Global
00:10:00
Howard Marks on Investment Philosophy, Risk, and Randomness | Oaktree Co-founder | In Good Company Podcast by Norges Bank Investment Management
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
Silver Market Outlook: Investment Trends and Price Dynamics
00:10:00
Night Ventures helps founders navigate new forms of customer acquisition|Reed Duchscher,General Partner,Night Ventures
00:10:00
Euro Manganese: Pioneering High-Purity Manganese Production for EV Batteries in Europe
00:10:00
Enhancing Financial Services with Docupace: A Partnership for Customized Solutions
00:10:00
Avoiding Financial Frenemies: Six Investing Mistakes You Can't Afford to Make
00:10:00
Focuses on early stage investments in technology companies|Ann Miura-Ko,Co-Founding Partner,Floodgate

© 2026 Nehu